Cargando…

Characterisation of genes encoding for extended spectrum β-lactamase in Gram-negative bacteria causing healthcare-associated infections in Mwanza, Tanzania

Healthcare-associated infections (HCAIs) caused by extended spectrum β-lactamase-producing Gram-negative bacteria (ESBL-GNB) increase morbidity and mortality. This cross-sectional study characterised ESBL genes (bla(CTX-M), bla(TEM) and bla(SHV)) among 30 ceftriaxone-resistant GNB causing HCAIs betw...

Descripción completa

Detalles Bibliográficos
Autores principales: Mwakyabala, Jenipher G., Mtemisika, Conjester I., Mshana, Stacy, Mwakyoma, Adam A., Silago, Vitus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AOSIS 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157427/
https://www.ncbi.nlm.nih.gov/pubmed/37151814
http://dx.doi.org/10.4102/ajlm.v12i1.2107
Descripción
Sumario:Healthcare-associated infections (HCAIs) caused by extended spectrum β-lactamase-producing Gram-negative bacteria (ESBL-GNB) increase morbidity and mortality. This cross-sectional study characterised ESBL genes (bla(CTX-M), bla(TEM) and bla(SHV)) among 30 ceftriaxone-resistant GNB causing HCAIs between January 2022 and July 2022 by multiplex polymerase chain reaction assay at the zonal referral hospital in Mwanza, Tanzania. Twenty-five (83.3%) had at least one ESBL gene, of which 23/25 (92.0%) carried the bla(CTX-M) gene. Seventy-two percent (18/25) of the GNB-ESBL isolates carried more than one ESBL gene, of which the majority (88.8%; n = 16/25) carried the bla(CTX-M) and bla(TEM) genes. Extended spectrum β-lactamase genes, particularly bla(CTX-M), are common among ceftriaxone-resistant GNB causing HCAIs. WHAT THIS STUDY ADDS: This study revealed the distribution of genes (bla(CTX-M), bla(TEM) and bla(SHV)) coding for ESBL production among ceftriaxone resistant GNB causing HCAIs However, all ESBL producing GNB were susceptible towards ceftriaxone-sulbactam indicating that ceftriaxone-sulbactam may be empirically prescribed for treating patients with HCAIs.